Corporate Clients

Realise potential, meet goals, and build value.

CG Results works as a trusted adviser to corporate clients, including some of the world’s leading pharmaceutical companies. Our clients know they can count on our track-record, depth of experience, professionalism and exceptional technical capabilities.

We work closely with corporate clients that need sector specialist advisors for their buy-side or sell-side M&A needs. Our solutions include strategic reviews of business or facility portfolios, support for acquisitions and divestments, as well as advising on licensing transactions for marketed products.

Commitment to client service is a hallmark of our project teams.

Our disciplined approach and strong technical capability allow our corporate clients to execute projects with confidence and achieve their strategic goals.

We pride ourselves on our integrity and straight talking, giving the best advice to our clients. We are focused on getting the best outcome: we think this demands an adviser who will be clear and considered however complex or pressurised the situation.

David Sanders

Managing Director

Services

We’ve been providing independent M&A and corporate finance advice and execution services to entrepreneurs, corporates and investors in the technology and healthcare sectors for over 30 years. Whether your aim is to realise value or to find a partner for future growth, we will be your guide.

M&A

When the time comes, we’re by your side every step of the way. We help you evaluate your market, find the right buyer, and deliver the true value of your business.

Divestments

With a strong track record in company carve-outs, we can help you realign your portfolio and redeploy capital to the growth of your core business.

Licensing

We support clients with in-licensing, out-licensing, drug licensing, and facility licensing and we understand the complexities that are unique to licensing deals.

Equity Fundraising

We understand that optimising terms is critical, but so is finding the right partner for growth. We help articulate your equity story, target the best investors and negotiate the right deal.

Strategic Advice

Having completed over 300 transactions, we bring the breadth of perspectives and depth of business experience to provide advice on strategic options for businesses.

Recent Deals

Nov 2022
has been acquired by
An Interlock Equity-backed company
Oct 2022
has been acquired by
A Trill Impact-backed company
Jul 2022
has received investment from
Jul 2022
has divested its API site in Rhode Island, USA, to
Jun 2022
A Kester Capital-backed company
has received investment from
Jun 2022
Has invested in
Jun 2022
has been acquired by
A company backed by GTCR and The Carlyle Group
May 2022
A subsidiary of Servier
has divested its anti-LAG-3 monoclonal antibody to
A subsidiary of Sino Biopharmaceutical Limited
Apr 2022
has received investment from
and EnBW New Ventures, with follow-on investment from ETF Partners
Apr 2022
has been acquired by
A company backed by TA Associates, HGGC, Charlesbank, Harvest Partners SCF

CG Results. Great people creating great outcomes, together.

Latest Insights

Reports
16th February 2023

Pharma Commercialisation Services Update – February 2023

Welcome to our latest update on the outsourced Pharma Commercialisation Services sector. In this report we will be reviewing deal activity across 2022 and taking a look forward to see what 2023 may hold for the sector. We hope that you enjoy this report and look forward to discussing the data and underlying themes with […]

Insights
5th December 2022

The end of the ecommerce boom or the start of a new era of innovation and digital disruption?

Katherine Hobbs, Director at CG Results and Neil Trickett Managing Director of E2X discuss the outlook for ecommerce and why, despite the headlines, they see opportunities for operators and investors across the sector over the next 18-24 months As Black Friday and Cyber Monday draw to a close, you could be forgiven for concluding that […]

Reports
23rd November 2022

Pharma Licensing – an introduction

We are pleased to share our introduction to Pharma Licensing. This guide provides an overview of both in and out-licensing as well as insights on what to anticipate during the process. We hope that you find this guide useful and look forward to discussing the underlying themes with you. Do get in touch! Click to […]